Back
Omnicom Group, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Buy
69
OMC
Omnicom Group, Inc.
Last Price:
$80.23
Seasonality Move:
5.92%
Sell
23
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$33.50
Seasonality Move:
-0.96%
Buy
69
Omnicom Group, Inc. (OMC)
is a Buy
Is Omnicom Group, Inc. a Buy, Sell or Hold?
-
The current Omnicom Group, Inc. [OMC] share price is $80.23. The Score for OMC is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
OMC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OMC Stock Price Chart
What is Omnicom Group, Inc.'s stock price today?
-
The Omnicom Group, Inc. share price today is $80.23The current trend is moderately bullish and OMC is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $33.50Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.
OMC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.94 | Buy |
| Relative Strength Index (14 RSI): | 61.75 | Buy |
| Chaikin Money Flow: | -7575281 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.19 - 78.97) | Buy |
| Bollinger Bands (100): | (73.22 - 79.06) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.24 | Buy |
| Relative Strength Index (14 RSI): | 45.54 | Sell |
| Chaikin Money Flow: | 579058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.65 - 35.95) | Sell |
| Bollinger Bands (100): | (29.19 - 34.19) | Buy |
OMC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 80.43 | Sell |
| 20-day SMA: | 75.73 | Buy |
| 50-day SMA: | 75.65 | Buy |
| 200-day SMA: | 75.63 | Buy |
| 8-day EMA: | 79.73 | Buy |
| 20-day EMA: | 77.19 | Buy |
| 50-day EMA: | 76.02 | Buy |
| 200-day EMA: | 77.79 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.82 | Sell |
| 20-day SMA: | 34.8 | Sell |
| 50-day SMA: | 33.74 | Sell |
| 200-day SMA: | 33.57 | Sell |
| 8-day EMA: | 17.59 | Buy |
| 20-day EMA: | 8.61 | Buy |
| 50-day EMA: | 3.75 | Buy |
| 200-day EMA: | 0.98 | Buy |
Omnicom Group, Inc. Earnings Growth & OMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $1.28 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
Omnicom Group, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||